author-photo

Noah Berkowitz

Novartis

42

Papers

1130

Citations

Citation Trend

Filter By

Papers (32) Sort By

Journal Conference Others

Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia

2019 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (7)
The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma

2018 Pediatric Nephrology
Show All
- Source
- Cite
- Save
Citations (18)
Trial in Progress: A Phase 3, Randomized, Double-Blind Study of Midostaurin in Combination with Chemotherapy and as Single-Agent Maintenance Therapy in Newly Diagnosed Patients with FLT3 Mutation–Negative Acute Myeloid Leukemia (AML)

2018 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (1)
Estimand Framework in AML Based on a Randomized, Placebo-Controlled, Phase 3 Study Investigating the Effect of Adding Midostaurin to Standard Chemotherapy in Patients with Newly Diagnosed AML without a FLT3 Mutation

2018 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia, results from two clinical trials

2018 Haematologica
Show All
- Source
- Cite
- Save
Citations (12)
Erratum: Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC (Annals of Oncology (2017) 28 (1339–1345) DOI: 10.1093/annonc/mdx075)

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (12)
Effect of everolimus on skin lesions in patients treated for subependymal giant cell astrocytoma and renal angiomyolipoma: final 4-year results from the randomized EXIST-1 and EXIST-2 studies

2018 Journal of The European Academy of Dermatology and Venereology
Show All
- Source
- Cite
- Save
Citations (14)
Concomitant Use of Midostaurin with Strong CYP3A4 Inhibitors: An Analysis from the Ratify Trial

2017 Blood
Show All
- Source
- Cite
- Save
Citations (14)
Pooled analysis of menstrual irregularities from three major clinical studies evaluating everolimus for the treatment of tuberous sclerosis complex

2017 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (7)
Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study

2017 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (76)